These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array. Mantripragada KK; Díaz de Ståhl T; Patridge C; Menzel U; Andersson R; Chuzhanova N; Kluwe L; Guha A; Mautner V; Dumanski JP; Upadhyaya M Genes Chromosomes Cancer; 2009 Oct; 48(10):897-907. PubMed ID: 19603524 [TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 1 (NF1): Identification of eight unreported mutations in NF1 gene in Italian patients [corrected]. Origone P; Bellini C; Sambarino D; Banelli B; Morcaldi G; La Rosa C; Stanzial F; Castellan C; Coviello DA; Garrè C; Bonioli E Hum Mutat; 2003 Aug; 22(2):179-80. PubMed ID: 12872266 [TBL] [Abstract][Full Text] [Related]
15. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084 [TBL] [Abstract][Full Text] [Related]
16. Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors. Lothe RA; Smith-Sørensen B; Hektoen M; Stenwig AE; Mandahl N; Saeter G; Mertens F Genes Chromosomes Cancer; 2001 Feb; 30(2):202-6. PubMed ID: 11135438 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours. Storlazzi CT; Brekke HR; Mandahl N; Brosjö O; Smeland S; Lothe RA; Mertens F J Pathol; 2006 Aug; 209(4):492-500. PubMed ID: 16721726 [TBL] [Abstract][Full Text] [Related]
18. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Mechtersheimer G; Otaño-Joos M; Ohl S; Benner A; Lehnert T; Willeke F; Möller P; Otto HF; Lichter P; Joos S Genes Chromosomes Cancer; 1999 Aug; 25(4):362-9. PubMed ID: 10398430 [TBL] [Abstract][Full Text] [Related]
19. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients. Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265 [TBL] [Abstract][Full Text] [Related]
20. Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group. Brekke HR; Ribeiro FR; Kolberg M; Agesen TH; Lind GE; Eknaes M; Hall KS; Bjerkehagen B; van den Berg E; Teixeira MR; Mandahl N; Smeland S; Mertens F; Skotheim RI; Lothe RA J Clin Oncol; 2010 Mar; 28(9):1573-82. PubMed ID: 20159821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]